Can a National Lung Cancer Screening Program in combination with smoking cessation policies cause an early decrease in tobacco deaths in Italy?

Cancer Prevention Research

Volumn 5, Issue 6, 2012, Pages 874-882

  Carreras, Giulia ^a   Gorini, Giuseppe ^a   Paci, Eugenio ^a  

^a Cancer Prevention and Research Institute ISPO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COUNSELING; FEMALE; FUNDING; HEALTH PRACTITIONER; HUMAN; ITALY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SMOKING ATTRIBUTABLE MORTALITY; SMOKING CESSATION PROGRAM; SMOKING HABIT; TAX;

AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; ITALY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NATIONAL HEALTH PROGRAMS; PROGNOSIS; RISK FACTORS; SMOKING; SMOKING CESSATION; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866442001     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0019     Document Type: Article

References (44)

1. World Health Organization, International Agency For Research On Cancer. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans.Volume 83. Lyon, France; 2004.
2. AIRT Working Group. Italian cancer figures-report 2009: Cancer trend (1998-2005). Epidemiol Prev 2009:33 Suppl 1:1-69.
3. WHO Framework Convention on Tobacco Control. World Health Organization, 2003. [cited 2011 Nov 14]. Available from: http://whqlibdoc.who.int/ publications/2003/9241591013.pdf.
4. WHO. WHO report on the global tobacco epidemic, 2011: warning about the dangers of tobacco, World Health Organization, 2011. [cited 2011 Nov 14]. Available from: 〈www.who.int/tobacco/mpower/2009/en/index.html〉.
5. Carreras G, Gorini G, Gallus S, Iannucci L, Levy DT. Predicting the future prevalence of cigarette smoking in Italy over the next three decades. Eur J Public Health 2011. Sep 5. [Epub ahead of print].
6. Carreras G, Gallus S, Iannucci L, Gorini G. Estimating the probabilities of making a smoking quit attempt in Italy: stall in smoking cessation levels, 1986-2009. BMC Public Health 2012;12:183.
7. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105. (Pubitemid 29313143)
8. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71. (Pubitemid 44631359)
9. Pastorino U, Bellomi M, Landoni C, De Fiori E, Arnaldi P, Picchio M, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003;362:593-7. (Pubitemid 37013298)
10. van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, et al. Risk-based selection from the general population in a screening trial:selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74. (Pubitemid 46175408)
11. Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, et al. The Danish Randomized lung cancer ct screening trial - overall design and results of the prevalence round. J Thorac Oncol 2009;4:608-14.
12. Lopes Pegna A, Picozzi G, Mascalchi M, Maria Carozzi F, Carrozzi L, Comin C, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009;64:34-40.
13. The National Lung Screening Trial Research Team. Baseline characteristics of participants in the randomized National Lung Screening Trial. J Natl Cancer Inst 2010;102:1771-9.
14. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
15. McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011;6:1841-8.
16. Wen CP, Tsai SP, Chen CJ, Cheng TY, Tsai MC, Levy DT. Smoking attributable mortality for Taiwan and its projection to 2020 under different smoking scenarios. Tob Control 2005;14 Suppl 1: i76-80. (Pubitemid 40806909)
17. Byers T, Mouchawar J, Marks J, Cady B, Lins N, Swanson GM, et al. The American Cancer Society challenge goals. How far can cancer rates decline in the U.S. by the year 2015? Cancer 1999;86:715-27. (Pubitemid 29379419)
18. Levy DT, Hyland A, Higbee C, Remer L, Compton C. The role of public policies in reducing smoking prevalence in California: results from the California tobacco policy simulation model. Health Policy 2007 82:167-85. (Pubitemid 46777059)
19. Italian Institute of Statistics (ISTAT). Multipurpose Surveys 1986 - 2009, ISTAT, Rome. [cited 2010 Sep 15]. Available from: 〈www.istat.it〉
20. Gallus S, Tramacere I, Boffetta P, Fernandez E, Rossi S, Zuccaro P, et al. Temporal changes of under-reporting of cigarette consumption in population-based studies. Tob Control 2011;20:34-9.
21. Peto R, Lopez AD, Boreham J, Thun M, Heath C Jr. Mortality from Smoking in Developed Countries 1950-2000. Oxford: Oxford University Press; 1994.
22. Italian Institute of Statistics (ISTAT). Demography in figures. [cited 2010 Dec 15]. Available from: http://demo.istat.it/.
23. US Department of Health and Human Services. The health bene fits of smoking cessation: a report of the Surgeon General. Rockville, MD: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health promotion, Office on Smoking and Health; 1990. DHHS publication (CDC) 90-8416.
24. Peto R, Lopez AD, Boreham J, Thun M. Mortality from smoking in developed Countries, 1950-2000, 2nd ed. 2006. [cited 2011 Nov 15]. Available from: 〈www.deathsfromsmoking.net〉.
25. Gallus S, Fernandez E, Townsend J, Schiaffino A, La Vecchia C. Price and consumption of tobacco in Italy over the last three decades. Eur J Cancer Prev 2003;12:333-7. (Pubitemid 36994090)
26. Gallus S., Fernandez E, Pacifici R, Colombo P, Zuccaro P, Bosetti C, et al. Channels of cigarette distribution, price and tobacco consumption in Italy. Prev Med 2006;42:132-4. (Pubitemid 43207420)
27. Levy DT, Graham AL, Mabry PL, Abrams DB, Orleans CT. Modeling the impact of smoking-cessation treatment policies on quit rates. Am J Prev Med 2010;38(3 Suppl):S364-72.
28. Zappa M, Grazzini G, Naldoni C, Paci E, Segnan N, Federici A. The diffusion of screening programmes in Italy: 2008. Epidemiol Prev 2010:34:suppl 4: S5-S8.
29. Ferketich AK, Gallus S, Colombo P, Pacifici R, Zuccaro P, La Vecchia C. Hardcore smoking among Italian men and women. Eur J Cancer Prev 2009;18:100-5.
30. Gallus S, Muttarak R, Martinez Sanchez JM, Zuccaro P, Colombo P, La Vecchia C. Smoking prevalence and smoking attributable mortality in Italy, 2010. Prev Med 2011;52:434-8.
31. Pacifici R. National Report on Smoking, 2011. In: Proceedings of the 9th National Congress on Tabagism and National Health System, Rome, May 31, 2011. Italian National Institue of Health [Italian]. [cited 2011 Aug 20]. Available from: http://www.iss.it/binary/ofad/cont/Rapporto-annuale-sul-fumo-anno2011.pdf.
32. The Italian behavioral risk factor surveillance system (PASSI). [cited 2011 Aug 20]. Available from: http://www.epicentro.iss.it/passi/english.asp.
33. DiPucchio A, Pizzi E, Carosi G, Mazzola M, Mattioli D, Pacifici R, et al. National survey of the smoking cessation services in Italy. Int J Environ Res Public Health 2009;6:915-26.
34. Telefono Verde contro il Fumo. [cited 2010 Sept]. Available from: 〈http://www.iss.it/ofad/serv/cont.php?id=3&lang=1&tipo=7〉.
35. Willemsen MC, van der Meer RM, Bot S. Results of the European Smoking Cessation Helplines Evaluation Project (ESCHER). Den Haag, The Netherlands, 2008. [cited 2011 Sept 15]. Available from: http://www.quit.org.uk/enq/ ESCHERFinalReport.pdf.
36. Blecher EH, van Walbeek CP. Cigarette affordability trends: an update and some methodological comments. Tob Control 2009;18:167-75.
37. Shibuya K, Ciecierski C, Guindon E, Bettcher DW, Evans DB, Murray CJ. WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty. BMJ 2003;327:154-7. (Pubitemid 36876212)
38. Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control 2007;16Suppl 1:i53-9.
39. FioreMC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Services. May 2008.
40. van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax 2010;65:600-5.
41. Hoogenveen RT, van Baal PHM, Boshuizen HC, Feenstra TL. Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation. Cost Eff Resour Alloc 2008;6:1.
42. Carozzi FM, Bisanzi S, Falini P, Sani C, Venturini G, Lopes Pegna A, et al. Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: perspectives of integrated strategies for early diagnosis. Lung Cancer 2010;68:216-21.
43. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 2011;108:3713-8.
44. Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-6. (Pubitemid 351161249)